Loader Background
Request a demo
Quantum Surgical SAS (Headquarters)
1000 rue du Mas de Verchant,
34000 Montpellier
Quantum Surgical Inc.
801 Brickell Avenue, Suite 809
Miami, FL 33131

An innovative solution for interventional oncology robotics

Our journey begins with lung, liver, kidney and pancreatic cancers which are one of the leading causes of cancer deaths worldwide.
Our Epione® device is CE marked for abdomen and lung tumors, and FDA cleared for abdominal tumors.

2,200,000 cases of lung cancer Diagnosed every year
+900,000 cases of liver cancer Diagnosed every year
+830,000 cases of pancreatic and kidney cancer Diagnosed every year

    Epione® in 4 simple steps


  • Define tumor/margin
  • Select ablation modality and number of probes
  • Visualize ablation zone coverage with 2D/3D image fusion software


  • Register robot to patient
  • Synchronize respiratory monitor
  • Place ablation probe in safety lock needle guide


  • Send robot to target down planned trajectory
  • Deliver ablative therapy per manufacturer guidelines


  • Take post-op CT and overlay with pre-op images to assess results
  • Compare tumor volume to ablation zone to confirm achievement of end-point

Epione®, an innovative solution for interventional oncology robotics

Epione® is an open robotic solution compatible with most commonly used imaging systems. The medical robot is designed to allow physicians to treat with their preferred ablative technologies (radiofrequency, microwave, cryoablation, irreversible electroporation) so they can decide the right therapy for each individual patient.

Epione® is designed to transform interventional oncology

Our goal is to dramatically ease multiple probe procedures which will make treatment of large tumors more predictable.

Epione® is a unique interventional oncology robot that offers 6 degrees of freedom and unprecedented dexterity to access difficult trajectories when targeting abdominal tumors.

Learn from the Epione users!

Listen to experts discussing about the impact of robotics on interventional radiology and what the Epione® robotic-assisted percutaneous ablation platform is bringing to their institutions.

Access the webinar


“ Utilizing Epione® at Gustave Roussy has allowed us to improve our procedure reproducibility. We’re able to plan and achieve more oblique needle trajectories and provide multi-needle treatment with insertion of each needle in less than 1 minute, thus expanding our tumor ablation practice.
Our patients interest is triggered by robotic technology that they accept for their treatment.”

Professor Thierry De Baere
Head of the therapeutic Imaging Department at Gustave Roussy Hospital.

“ The Epione robot delivers all its promises. We are very excited to continue to explore the many benefits of Epione and to support the next steps in the development of robotics in interventional radiology. This will undoubtedly lead to significant progress and extend hope for patients we do not have treatment solutions for so far.”

Professor Laurent Milot
Head of Interventional Radiology at Hospices Civiles de Lyon.

Epione® solution combines:

Multimodal Planning

  • Fusion of CT and MRI images
  • Enhance the visualization of the tumor

Respiratory Monitoring

  • Real-time respiration tracking
  • Synchronization of respiration
    for probe placement

Post-Ablation Treatment Confirmation

  • Fusion of pre-and post-ablation images
  • Verification of ablation margins
    after treatment

Robotic Guidance with Navigation & Haptics

  • 6 degrees of freedom for unprecedented dexterity
  • Universal needle guide
  • Quick & safe needle release

Epione® device is CE marked and FDA cleared.

For product information, including indications, contraindications, warnings, precautions, and potential adverse effects, refer to the package insert. To obtain a copy of the current Instructions for Use (IFU) for full prescribing and risk information, please reach the technical support at +33-448-194-050


Quantum Surgical is recruiting

At Quantum Surgical, we are recruiting the brightest minds and most creative innovators that thrive in a start-up environment.